Skip to main content

Biotech Networking Event with Johnson & Johnson Innovation in Switzerland (EN)

BaseLaunch invites you to this biotech networking event on 23 November 2022, empowered by Innosuisse featuring Johnson & Johnson Innovation.

Johnson & Johnson Innovation will present its external collaboration model and meet innovative emerging companies and start-ups, as well as researchers, academics and organizations based in Switzerland and active in the pharmaceutical, medical device and consumer health sectors.

 

The event will take place in person at Halle 7 in Basel and will include:

  • An interactive briefing on the Johnson & Johnson Innovation collaboration model in Switzerland, including customized deal structures, company creation, incubation and startup services, capital investments and other business models that aim to meet the diverse needs of entrepreneurs, scientists and emerging companies.
  • A panel discussion with key opinion leaders on “How can Swiss life sciences startups compete globally?”
  • A networking reception

Johnson & Johnson Innovation works across the pharmaceutical, medical device and consumer health sectors to accelerate early-stage, transformational solutions by catalyzing the best ideas, wherever they are in the world. The goal is to help life science and health technology innovations thrive through collaboration and partnership with the global ecosystem, so that together we can change the trajectory of human health.

Program

15:30

Door opening

16:00

Welcome & Introduction by BaseLaunch
Stephan Emmerth, Director Business Development & Operations

16:05

Welcome & Introduction by Johnson & Johnson Innovation
Andrea Ostinelli, Managing Director External Partnerships & Head of Campus Switzerland, Johnson & Johnson

16:10

The Johnson & Johnson Innovation Collaboration Model
Nerida Scott, Regional Head of Johnson & Johnson Innovation EMEA
Fiona MacLaughlin, Principal, Venture Investments, Johnson & Johnson Innovation – JJDC
Elena Fernandez-Kleinlein, Head of JLABS EMEA, Johnson & Johnson Innovation

16:40

Johnson & Johnson Innovation in Switzerland
Michael Hübner, Director Early Innovation Partnering Switzerland, Johnson & Johnson Innovation

16:45

Q & A

16:55

Panel discussion: How can Swiss life sciences startups compete globally?
Sarah Holland | CEO, IOME Bio S.A. and President Swiss Healthcare Licensing Group
Michael Hübner (moderator) | Director Early Innovation Partnering Switzerland, Johnson & Johnson Innovation
Martin Münchbach | Managing Partner, Pureos Bioventures
Nerida Scott | Head of Johnson & Johnson Innovation EMEA
Susanne Weissbäcker | Partner at EY-Parthenon, Life Sciences Strategy

17:35

Q & A

17:45

Networking Apéro

Participation is free, however registration is required before September 16, 2022.

Our partner